| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |